OR4P4

Across TCGA pan-cancer cohorts, OR4P4 RNA is linked to patient survival in 4 of 34 cancer types, making it a survival-associated OR4P4 data layer compared with 6 for mutation status and 1 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR4P4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR4P4 expression acts as an unfavorable survival marker.

STAD, SKCM, and SARC are the cancer types where OR4P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.390	0.729	.001	36	view →
SKCM	OS	Tertile	II,III,IV	0.241	0.845	<.001	27	view →
SARC	OS	Tertile	All	0.175	0.730	.009	27	view →
THCA	OS	Tertile	All	0.240	0.931	<.001	24	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

OR4P4–STAD (DFS)

Open the STAD breakdown →